Here's how analysts see Karyopharm Therapeutics Inc. (NASDAQ:KPTI) after this past week.

Retrieved on: 2018-01-09 05:45:00

Tags for this article:

Finance

NASDAQ

Economy of the United States

Investment

Kernel page-table isolation

Virtual memory

Click the tags to see associated articles and topics

Here's how analysts see Karyopharm Therapeutics Inc. (NASDAQ:KPTI) after this past week.. View article details on hiswai:

Excerpt

<div><b>Millennium Management</b> Limited Liability Corporation reported 0.01% stake. Moreover, Metropolitan Life Insurance has 0% invested in Karyopharm Therapeutics Inc. (NASDAQ:KPTI) for 21,911 shares. Raymond James Assocs holds 0% of its portfolio in Karyopharm Therapeutics Inc. (NASDAQ:KPTI) ...</div>

Article found on:

View Original Article